HomeTagsNanjing

Nanjing

Biotechnology

IASO Bio’s Nanjing Manufacturing Facility Granted the Drug Manufacturing License for CAR-T Cell Therapy Products

PR Newswire - March 2, 2022

IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products announced that the company's commercial manufacturing...

Healthcare

CTB001, Bioheng auto CAR – T Product, received Orphan Drug Designation (ODD) from the U.S. FDA

PR Newswire - January 31, 2022

Recently, Nanjing Bioheng Biotech Co., Ltd. ( hereinafter referred to as Bioheng) announced that its anti-claudin 18.2 autologous CAR-T cell therapy product CTB001 received Orphan Drug Designation...

Biotechnology

InnoCare and Keymed Jointly Announce Dosing of First Patient in Clinical Trial of CD20xCD3 Bispecific Antibody CM355

PR Newswire - January 18, 2022

InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the first patient in China has been dosed in clinical trial...

Carbon Management: Importance, Examples, and Key Strategies

Tim Holley Joins MyFitnessPal as Chief Product Officer

Eivind Kallevik appointed as Hydro’s new President and CEO

Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable…

Nanjing

Hot Topics

Carbon Management: Importance, Examples, and Key Strategies

Unveiling the Power of 5G RF Transceivers: The Backbone of Next-Gen Connectivity

Tim Holley Joins MyFitnessPal as Chief Product Officer